Dr. Hannah Kettler
Senior Program Officer, Life Sciences Partnerships
Hannah Kettler, Ph.D., is a Senior Program Officer on the Life Sciences Partnerships team at the Bill and Melinda Gates Foundation, where she is responsible for the LSP Thinkubator and Leadership Engagement Initiatives. In this role, she manages the Gates-CEO Roundtable, a coalition between the CEOs of 17 global pharmaceutical and diagnostics companies and Gates Foundation leadership and the foundation’s grant with Japan’s Global Health Investment Fund. Dr. Kettler’s work focuses on the intersection of industry, finance, and global health & policy. She is passionate about designing innovative partnerships and sustainable financing vehicles and policy change to mobilize corporate investment in global health.
During her 15 years at the Gates Foundation, she has had previous roles including MNC Sector team lead, Deputy Director for Policy and Finance, and Senior Program Officer for R&D advocacy and funding. She has served on the Gilead Health Policy Advisory Board since 2012 and is a Senior Lecturer at MIT Sloan School of Management. Prior to joining the Gates Foundation in 2003, Dr. Kettler directed a two-year project funded by Rockefeller Foundation titled “Biotechnology and Global Health” at the Institute for Global Health at the University of California San Francisco. In 2004, she partnered with BIO and the Bill and Melinda Gates Foundation to launch BIO Ventures for Global Health, a nonprofit organization established to enable the engagement of biotechnology companies in solving global health problems.
Between 1998 and 2001, Dr. Kettler worked as the Senior Industrial Economist for the Office of Health Economics (OHE) within the Association for British Pharmaceutical Industry in London. There she published on the economics and political economy of innovation in the pharmaceutical and biotechnology industries in the US, UK and Germany.
She has a Ph.D. in Industrial Economics from the University of Notre Dame.